Media.Player

Identification Of New Synthetic Elicitors Of Plant Immune Responses

Technology Benefits

Better control of defense signaling network – new compound’s regulatory step lies upstream of salicylic acid, the defense hormone in plantsBiological activity is 10-fold higherImproved protection along with enhanced immune system & growthComplement or substitute pesticide use

Technology Application

Development of disease-resistant plant lines Compounds can be formulated in various ways depending on necessity (e.g. liquid, powder, gas)

Detailed Technology Description

Background: The global market for agricultural biotechnology is projected to reach $46.8B. What’s encouraging this 11% industry growth over the next 4 years are pathogens. Pathogens are very adaptive, multifaceted and rapidly acquire new traits that enable their survival. One of their most notable traits is the ability to release effector molecules and suppress plant immunity, thereby increasing disease spread and infection. Plants, too, have evolved in their defense signaling networks but it is more effective to find a preventative measure, as more energy is expended when trying to recuperate from post-infection.   Brief Description: UCR Researchers have identified new synthetic elicitors that are involved in the earlier stages of plant defense signaling. These compounds have a more extensive effect on plant immune responses than the existing synthetic elicitor, DCA. It has been successfully verified that the new compound exhibits higher potency in mediating disease resistance against harmful pathogens as well as enhance the plant’s inherent defense system.

Application No.

9622472

Others

Images

Wikimedia Commons / https://commons.wikimedia.org/wiki/File:CSIRO_ScienceImage_10772_Rustaffected_wheat_seedlings.jpg

Tech ID/UC Case

25185/2011-097-0

Related Cases

2011-097-0

*Abstract

None

*Applications

• Development of disease-resistant plant lines
• Compounds can be formulated in various ways depending on necessity (e.g. liquid, powder, gas)

*IP Issue Date

Apr 18, 2017

*Principal Investigator

Name: Thomas Eulgem

Department:

Name: Colleen Knoth

Department:

Name: Melinda Rodriguez-Salus

Department:

Country/Region

USA